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Abstract 
We have previously reported that the expression of the CL2/CCDC80 gene is downregulated in human papillary thyroid 
carcinomas, particularly in follicular variants. We have also reported that the restoration of CL2/CCDC80 expression 
reverted the malignant phenotype of thyroid carcinoma cell lines and that CL2/CCDC80 positively regulated E-cadherin 
expression, an ability that likely accounts for the role of the CL2/CCDC80 gene in thyroid cancer progression. In order 
to validate the tumour suppressor role of the CL2/CCDC80 gene in thyroid carcinogenesis we generated cl2/ccdc80 
knock-out mice. We found that embryonic fibroblasts from cl2/ccdc80(-/-) mice showed higher proliferation rate and 
lower susceptibility to apoptosis. Furthermore, cl2/ccdc80(-/-) mice developed thyroid adenomas and ovarian 
carcinomas. Finally, ret/PTC1 transgenic mice crossed with the cl2/ccdc80 knock-out mice developed more aggressive 
thyroid carcinomas compared with those observed in the single ret/PTC1 transgenic mice. Together, these results 
indicate CL2/CCDC80 as a putative tumour suppressor gene in human thyroid carcinogenesis.  
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